Loss of synaptic D1 dopamine/N-methyl-D-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesia in the rat

Molecular Pharmacology

Volumn 69, Issue 3, 2006, Pages 805-812

  Fiorentini, Chiara ^a   Rizzetti, Maria Cristina ^a   Busi, Chiara ^a   Bontempi, Sandra ^a   Collo, Ginetta ^a   Spano, PierFranco ^a,b   Missale, Cristina ^a,b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b IRCCS SAN CAMILLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 1 RECEPTOR; GLUTAMATE RECEPTOR; LEVODOPA; MEMBRANE PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B;

AKINESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR THERAPY; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG INHIBITION; DRUG MECHANISM; DYSKINESIA; LOCOMOTION; MALE; MOTOR DYSFUNCTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

ANIMALS; ANTIPARKINSON AGENTS; CELLS, CULTURED; CORPUS STRIATUM; DYSKINESIA, DRUG-INDUCED; HUMANS; LEVODOPA; MALE; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; PROTEIN SUBUNITS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPSES; TRANSFECTION;

EID: 33644841226     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.016667     Document Type: Article

References (40)

1. Apperson ML, Moon IS, and Kennedy MB (1996) Characterization of densin-180, a new brain-specific synaptic protein of the O-sialoglycoprotein family. J Neurosci 16:6839-6852.
2. Aubert I, Guigoni C, Hakansson K, Li Q, Barche N, Bioulac BH, Gross CE, Fisone G, Bloch B, and Bezard E (2005) Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. Ann Neurol 57:17-26.
3. Barria A and Malinow R (2005) NMDA receptor subunit composition controls synaptic plasticity by regulating binding to CaMKII. Neuron 48:289-301.
4. Bezard E, Brotchie JM, and Gross CE (2001) Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat Rev Neurosci 2:577-588.
5. Brotchie JM (2005) Nondopaminergic mechanisms in levodopa-induced dyskinesia. Mov Dis 20:919-931.
6. Cenci MA, Lee CS, and Bjorklund A (1998) L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur J Neurosci 10:2694-2706.
7. Centonze D, Gubellini P, Picconi B, Calabresi P, Giacomini P, and Bernardi G (1999) Unilateral dopamine denervation blocks corticostriatal LTP. J Neurophysiol 82:3575-3579.
8. Chase TN and Oh JD (2000) Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism. Trends Neurosci 23 (10 Suppl):S86-S91.
9. Dingledine RT, Borges K, Bowie D, and Traynelis SF (1999) The glutamate receptor ion channels. Pharmacol Rev 51:7-61.
10. Dunah AW and Standaert DG (2001) Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. J Neurosci 21:5546-5558.
11. Dunah AW and Standaert DG (2003) Subcellular segregation of distinct heteromeric NMDA glutamate receptors in the striatum. J Neurochem 85:935-943.
12. Dunah AW, Wang Y, Yasuda RP, Kameyama K, Huganir RL, Wolfe BB, and Standaert DG (2000) Alterations in subunit expression, composition and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Mol Pharmacol 57:342-352.
13. Fiorentini C, Gardoni F, Spano PF, Di Luca M, and Missale C (2003) Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors. J Biol Chem 278:20196-20202.
14. Gardoni F, Caputi A, Cimino M, Pastorino L, Cattabeni F, and Di Luca M (1998) Calcium/Calmodulin-dependent protein kinase II is associated with NR2A/B subunits of NMDA receptor in postsynaptic densities. J Neurochem 71:1733-1741.
15. Gerfen CR, Miyachi S, Paletzi R, and Brown P (2002) D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of Erk1/2MAPkinase. J Neurosci 22:5042-5054.
16. Hallett PJ, Dunah AW, Ravenscroft P, Zhou S, Bezard E, Crossman AR, Brotchie JM, and Standaert DG (2005) Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Pakinson's disease. Neuropharmacology 48:503-516.
17. Kennedy MB (2000) Signal-processing machines at the postsynaptic density. Science (Wash DC) 290:750-754.
18. Lee FJ, Xue S, Pei L, Vukusic B, Chéry N, Wang Y, Wang YT, Niznik HB, Yu X, and Liu F (2002) Dual regulation of NMDA receptor functions by direct protein-protein interaction with the dopamine D1 receptor. Cell 111:219-230.
19. Lundblad M, Andersson M, Winkler C, Kirk D, Wierup N, and Cenci MA (2002) Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. Eur J Neurosci 15:120-132.
20. Luttrell LM and Lefkowitz RJ (2002) The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci 115:455-465.
21. Missale C, Nash R, Robinson SW, Jaber M, and Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78:189-225.
22. Mu Y, Otsuka T, Horton AC, Scott DB, and Ehlers MD (2003) Activity-dependent mRNA splicing controls ER export and synaptic delivery of NMDA receptors. Neuron 40:581-594.
23. Muriel MP, Bernard V, Levey AI, Laribi O, Abrous DN, Agid Y, Bloch B, and Hirsch HC (1999) Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease. Ann Neurol 46:103-111.
24. Nicola SM, Surmeier DJ, and Malenka RC (2000) Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu Rev Neurosci 23:185-215.
25. Obeso JA, Olanou CW, and Nutt JG (2000) Levodopa motor complications in Parkinson's disease. Trends Neurosci 23(10 Suppl):S2-S7.
26. Oh JD, Russel D, Vaughan CL, and Chase TN (1998) Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration. Brain Res 813:150-159.
27. Oh JD, Vaughan CL, and Chase TN (1999) Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits. Brain Res 821:433-442.
28. Papa SM and Chase TN (1996) Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys. Ann Neurol 39:574-578.
29. Papa SM, Engber TM, Kask AM, and Chase TN (1994) Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration. Brain Res 662:69-74.
30. Paul S, Nairn AC, Wang P, and Lombroso PJ (2003) NMDA-mediated activation of tyrosine phosphatase STEP regulates the duration of ERK signalling. Nat Neurosci 6:34-42.
31. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego, CA.
32. Picconi B, Centonze D, Hakansson K, Bernardi G, Greengard P, Fisone G, Cenci MA, and Calabresi P (2003) Loss of bidirectional striatal plasticity in L-DOPA-induced dyskinesia. Nat Neurosci 6:501-506.
33. 2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. J Neurosci 24:5283-5291.
34. Robelet S, Melon C, Guillet B, Salin P, and Kerkerian-Le Goff L (2004) Chronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease. Eur J Neurosci 20:1255-1266.
35. Roche KW, Standley S, McCallum J, Ly CD, Ehlers MD, and Wenthold RJ (2001) Molecular determinants of NMDA receptor internalization. Nat Neurosci 4:794-802.
36. Schallert T, Fleming SM, Leasure JL, Tillerson JL, and Bland ST (2000) CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39:777-787.
37. Thomas GM and Huganir RL (2004) MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci 5:173-183.
38. Yao WD, Gainetdinov RR, Arbuckle MI, Sotnikova TD, Cyr M, Beaulieu JM, Torres GE, Grant SGN, and Caron M (2004) Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioural plasticity. Neuron 41:625-638.
39. Yu XM, Askalan R, Keil GJ, and Salter MW (1997) NMDA channel regulation by channel-associated protein tyrosine kinase src. Science (Wash DC) 275:674-678.
40. Zukin RS and Bennett MLV (1995) Alternatively spliced isoforms of the NMDAR1 receptor subunit. Trends Neurosci 18:306-313.